PFIZER

Pfizer is a leader in corporate governance, and good corporate governance is fundamental to

their business. A cornerstone of governance at Pfizer is their shareholder outreach program,
through which they regularly engage with investors and stakeholders around the world to gain
insight into the burgeoning issues at the forefront of their business policies and guidelines. They
aim to seek a more collaborative approach to specific issues of importance in the industry.
Shareholder input helps to continue to drive innovations in policies and disclosures on corporate
political activities and other key governance areas.

Pfizer’s annually elected board of directors is comprised entirely of independent directors other
than their Executive Chairman, Ian Read, and CEO, Albert Bourla. Each Director provides a unique
business perspective, experience and skills, all valuable to the Company. The board plays a vital
oversight role, which fosters shareholder value and affects stakeholder confidence.

EVALUATION OF BOARD EFFECTIVENESS

The performance of Pfizer in the recent past has been shown below: